Give more independence to the Scots—paired with a statement that there will be no more votes for a long time to come
The move comes as GM's blue-chip brand is finally considered in range of—if not quite on par with—the best German luxury rides
Unresolved economic conflicts simmer during a tenuous cease-fire
In becoming Oracle's chairman and chief technology officer, Ellison will leave the software giant he founded in the hands of co-chief executive officers Mark Hurd and Safra Katz
The popular premixed funds are supposed to get more conservative as retirement gets closer. What “conservative” means is open to interpretation
With "activity-based working," you lose your desk and gain your freedom—all for better efficiency
The NFL is facing its worst crisis in 50 years. Why is Commissioner Goodell so sure he won't lose his job?
Two dozen live shows will broadcast professors' ideas for 40 hours a week, serving as a way to broaden Wharton's reach
A report finds high default rates on franchise loans
Founders: Cam Garner, Elaine Phillips, Malcolm Hill, and Adam Simpson
VC Investment over the last four quarters: $22.5 million
Founded in 2008, this nine-employee drug company develops products for the treatment of allergic inflammation of the gastrointestinal tract. "We identified a market that we believe has a true unmet medical need—in this particular instance there is no product approved by the FDA for the treatment of eosinophilic esophagitis," says a Meritage spokesperson in an e-mail. In the midst of the recession, its founders say that it is particularly important to stay focused on execution.
Key to startup success: "If we are able to successfully develop safe and effective products to meet the unmet medical needs of patients and their caregivers, we believe that capital will continue to be available."